Influence of long-term growth hormone replacement on leptin and ghrelin in GH deficiency before and after glucose load

Regulatory Peptides

Volumn 158, Issue 1-3, 2009, Pages 40-46

  Roemmler, J ^a   Kuenkler, M ^a   Otto, B ^a   Arafat, A M ^b   Bidlingmaier, M ^a   Schopohl, J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

GH deficient patients; GH substitution; OGTT; Pituitary

Indexed keywords

GHRELIN; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; LEPTIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GLUCOSE TOLERANCE TEST; GROWTH HORMONE DEFICIENCY; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; INSULIN RESISTANCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; PRIORITY JOURNAL; REGULATORY MECHANISM;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BODY COMPOSITION; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; GHRELIN; GLUCOSE; GROWTH HORMONE; HUMANS; LEPTIN; MALE; MIDDLE AGED;

EID: 70349739077     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2009.07.001     Document Type: Article

References (43)

1. Hamann A., and Matthaei S. Regulation of energy balance by leptin. Exp Clin Endocrinol Diabetes 104 (1996) 293-300
2. Corica F., Corsonello A., Ientile R., De Gregorio T., Malara A., Artemisia A., and Buemi M. Leptin and norepinephrine plasma concentrations during glucose loading in normotensive and hypertensive obese women. Am J Hypertens 14 (2001) 619-626
3. Bougoulia M., Tzotzas T., Efthymiou H., Koliakos G., Konstantinidis T., Triantos A., and Krassas G.E. Leptin concentrations during oral glucose tolerance test (OGTT) in obese and normal weight women. Int J Obes Relat Metab Disord 23 (1999) 625-628
4. Tschop M., Weyer C., Tataranni P.A., Devanarayan V., Ravussin E., and Heiman M.L. Circulating ghrelin levels are decreased in human obesity. Diabetes 50 (2001) 707-709
5. Shiiya T., Nakazato M., Mizuta M., Date Y., Mondal M.S., Tanaka M., Nozoe S., Hosoda H., Kangawa K., and Matsukura S. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87 (2002) 240-244
6. Torsello A., Bresciani E., Avallone R., and Locatelli V. [Ghrelin and GH secretion]. Minerva Endocrinol 27 (2002) 257-264
7. Otto B., Spranger J., Benoit S.C., Clegg D.J., and Tschop M.H. The many faces of ghrelin: new perspectives for nutrition research?. Br J Nutr 93 (2005) 765-771
8. Baldelli R., Bellone S., Castellino N., Petri A., Rapa A., Vivenza D., Bellone J., Broglio F., Ghigo E., and Bona G. Oral glucose load inhibits circulating ghrelin levels to the same extent in normal and obese children. Clin Endocrinol (Oxf) 64 (2006) 255-259
9. Gertner J.M. Growth hormone actions on fat distribution and metabolism. Horm Res 38 Suppl 2 (1992) 41-43
10. Cappiello V., Ronchi C., Morpurgo P.S., Epaminonda P., Arosio M., Beck-Peccoz P., and Spada A. Circulating ghrelin levels in basal conditions and during glucose tolerance test in acromegalic patients. Eur J Endocrinol 147 (2002) 189-194
11. Kawamata T., Inui A., Hosoda H., Kangawa K., and Hori T. Perioperative plasma active and total ghrelin levels are reduced in acromegaly when compared with in nonfunctioning pituitary tumours even after normalization of serum GH. Clin Endocrinol (Oxf) 67 (2007) 140-144
12. Tschop M., Flora D.B., Mayer J.P., and Heiman M.L. Hypophysectomy prevents ghrelin-induced adiposity and increases gastric ghrelin secretion in rats. Obes Res 10 (2002) 991-999
13. Giavoli C., Cappiello V., Corbetta S., Ronchi C.L., Morpurgo P.S., Ferrante E., Beck-Peccoz P., and Spada A. Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults. Clin Endocrinol (Oxf) 61 (2004) 81-87
14. Joaquin C., Aguilera E., Granada M.L., Pastor M.C., Salinas I., Alonso N., and Sanmarti A. Effects of GH treatment in GH-deficient adults on adiponectin, leptin and pregnancy-associated plasma protein-A. Eur J Endocrinol 158 (2008) 483-490
15. Eden Engstrom B., Burman P., Holdstock C., and Karlsson F.A. Effects of growth hormone (GH) on ghrelin, leptin, and adiponectin in GH-deficient patients. J Clin Endocrinol Metab 88 (2003) 5193-5198
16. Jung C.H., Lee W.Y., Rhee E.J., Kim S.Y., Oh K.W., Yun E.J., and Kim S.W. Serum ghrelin and leptin levels in adult growth hormone deficiency syndrome. Arch Med Res 37 (2006) 612-618
17. Malik I.A., English P.J., Ghatei M.A., Bloom S.R., MacFarlane I.A., and Wilding J.P. The relationship of ghrelin to biochemical and anthropometric markers of adult growth hormone deficiency. Clin Endocrinol (Oxf) 60 (2004) 137-141
18. Roemmler J., Otto B., Steffin B., Bidlingmaier M., and Schopohl J. Serum leptin and ghrelin levels in active and inactive acromegalic patients during an oral glucose tolerance test. Exp Clin Endocrinol Diabetes 117 3 (2008) 135-161
19. Elmlinger M.W., Kuhnel W., Weber M.M., and Ranke M.B. Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3). Clin Chem Lab Med 42 (2004) 654-664
20. Bristow A.F., Gooding R.P., and Das R.E. The international reference reagent for insulin-like growth factor-I. J Endocrinol 125 (1990) 191-197
21. Wu Z., Bidlingmaier M., Liu C., De Souza E.B., Tschop M., Morrison K.M., and Strasburger C.J. Quantification of the soluble leptin receptor in human blood by ligand-mediated immunofunctional assay. J Clin Endocrinol Metab 87 (2002) 2931-2939
22. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
23. Matsuda M., and DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22 (1999) 1462-1470
24. Miyakawa M., Tsushima T., Murakami H., Isozaki O., Demura H., and Tanaka T. Effect of growth hormone (GH) on serum concentrations of leptin: study in patients with acromegaly and GH deficiency. J Clin Endocrinol Metab 83 (1998) 3476-3479
25. al-Shoumer K.A., Anyaoku V., Richmond W., and Johnston D.G. Elevated leptin concentrations in growth hormone-deficient hypopituitary adults. Clin Endocrinol (Oxf) 47 (1997) 153-159
26. Fisker S., Vahl N., Hansen T.B., Jorgensen J.O., Hagen C., Orskov H., and Christiansen J.S. Serum leptin is increased in growth hormone-deficient adults: relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year. Metabolism 46 (1997) 812-817
27. De Lorenzo A., Bertini I., Iacopino L., Pagliato E., Testolin C., and Testolin G. Body composition measurement in highly trained male athletes. A comparison of three methods. J Sports Med Phys Fitness 40 (2000) 178-183
28. Ravaglia G., Forti P., Maioli F., Boschi F., Cicognani A., and Gasbarrini G. Measurement of body fat in healthy elderly men: a comparison of methods. J Gerontol A Biol Sci Med Sci 54 (1999) M70-M76
29. Saad M.F., Khan A., Sharma A., Michael R., Riad-Gabriel M.G., Boyadjian R., Jinagouda S.D., Steil G.M., and Kamdar V. Physiological insulinemia acutely modulates plasma leptin. Diabetes 47 (1998) 544-549
30. Jenkins A.B., Markovic T.P., Fleury A., and Campbell L.V. Carbohydrate intake and short-term regulation of leptin in humans. Diabetologia 40 (1997) 348-351
31. Imbeault P., Doucet E., Mauriege P., St-Pierre S., Couillard C., Almeras N., Despres J.P., and Tremblay A. Difference in leptin response to a high-fat meal between lean and obese men. Clin Sci (Lond) 101 (2001) 359-365
32. Giusti M., Bocca L., Florio T., Corsaro A., Spaziante R., Schettini G., and Minuto F. In vitro effect of human recombinant leptin and expression of leptin receptors on growth hormone-secreting human pituitary adenomas. Clin Endocrinol (Oxf) 57 (2002) 449-455
33. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
34. Broglio F., Gotter C., Prodam F., Destefanis S., Gauna C., Me E., Riganti F., Vivenza D., Rapa A., Martina V., Arvat E., Bona G., van der Lely A.J., and Ghigo E. Ghrelin secretion is inhibited by glucose load and insulin-induced hypoglycaemia but unaffected by glucagon and arginine in humans. Clin Endocrinol (Oxf) 61 (2004) 503-509
35. Jarkovska Z., Rosicka M., Marek J., Hana V., Weiss V., Justova V., Lacinova Z., Haluzik M., and Krsek M. Plasma levels of total and active ghrelin in acromegaly and growth hormone deficiency. Physiol Res 55 (2006) 175-181
36. Janssen J.A., van der Toorn F.M., Hofland L.J., van Koetsveld P., Broglio F., Ghigo E., Lamberts S.W., and Jan van der Lely A. Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy. Eur J Endocrinol 145 (2001) 711-716
37. Soriano-Guillen L., Barrios V., Martos G., Chowen J.A., Campos-Barros A., and Argente J. Effect of oral glucose administration on ghrelin levels in obese children. Eur J Endocrinol 151 (2004) 119-121
38. Caixas A., Bashore C., Nash W., Pi-Sunyer F., and Laferrere B. Insulin, unlike food intake, does not suppress ghrelin in human subjects. J Clin Endocrinol Metab 87 (2002) 1902
39. Freda P.U., Reyes C.M., Conwell I.M., Sundeen R.E., and Wardlaw S.L. Serum ghrelin levels in acromegaly: effects of surgical and long-acting octreotide therapy. J Clin Endocrinol Metab 88 (2003) 2037-2044
40. Flanagan D.E., Evans M.L., Monsod T.P., Rife F., Heptulla R.A., Tamborlane W.V., and Sherwin R.S. The influence of insulin on circulating ghrelin. Am J Physiol Endocrinol Metab 284 (2003) E313-E316
41. Anderwald C., Brabant G., Bernroider E., Horn R., Brehm A., Waldhausl W., and Roden M. Insulin-dependent modulation of plasma ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients. Diabetes 52 (2003) 1792-1798
42. Anderwald-Stadler M., Krebs M., Promintzer M., Mandl M., Bischof M.G., Nowotny P., Kastenbauer T., Luger A., Prager R., and Anderwald C. Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans. Am J Physiol Endocrinol Metab 293 (2007) E1393-E1398
43. Anderwald C., Anderwald-Stadler M., Promintzer M., Prager G., Mandl M., Nowotny P., Bischof M.G., Wolzt M., Ludvik B., Kastenbauer T., Pacini G., Luger A., and Krebs M. The Clamp-like index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects. Diabetes Care 30 (2007) 2374-2380